Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opini...
Guardado en:
Autores principales: | Antonio Greco, Davide Capodanno |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40721f3379a848deb4f209169266fe5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation
por: John Phineas O’Donnell, et al.
Publicado: (2019) -
Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation
por: Shu-I Lin, et al.
Publicado: (2020) -
Chimney Stenting During Transcatheter Aortic Valve Implantation
por: Liesbeth Rosseel, et al.
Publicado: (2020) -
Corrigendum to: Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation
por: Shu-I Lin, et al.
Publicado: (2020) -
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes
por: Alessandra Laricchia, et al.
Publicado: (2019)